EXOSC3 抗体
Quick Overview for EXOSC3 抗体 (ABIN2720622)
抗原
See all EXOSC3 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Homo sapiens exosome component 3 (EXOSC3), transcript variant 1
-
纯化方法
- Purified from mouse ascites fluids by affinity chromatography
-
免疫原
- Full length human recombinant protein of human EXOSC3(NP_057126) produced in E.coli.
-
亚型
- IgG1
-
-
anti-Exosome Component 3 (EXOSC3) (AA 1-275) antibody
EXOSC3 适用: 人 WB, ELISA, IP, IHC (p) 宿主: 小鼠 Monoclonal 5C3 unconjugated
anti-Exosome Component 3 (EXOSC3) (AA 1-275) antibodyEXOSC3 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) (AA 1-275) antibodyEXOSC3 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) (AA 176-274) antibodyEXOSC3 适用: 人 ELISA, IP 宿主: 小鼠 Monoclonal 3E5 unconjugated
anti-Exosome Component 3 (EXOSC3) (C-Term) antibodyEXOSC3 适用: 人, 小鼠, 犬, Cow, 豚鼠, 马, 兔, Pig, 猴, Bat WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) (AA 81-130) antibodyEXOSC3 适用: 人, 小鼠, 犬, Cow, 豚鼠, 马, 兔, Pig, 猴, 小鸡, 非洲爪蟾 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) antibodyEXOSC3 适用: 人 WB, FACS 宿主: 小鼠 Monoclonal 1D6 unconjugated
anti-Exosome Component 3 (EXOSC3) (C-Term) antibodyEXOSC3 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) (Middle Region) antibodyEXOSC3 适用: 人, 小鼠, 大鼠, 犬 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Exosome Component 3 (EXOSC3) (AA 1-275) antibodyEXOSC3 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB 1:2000, FLOW 1:100,
-
说明
-
The concentration of the product may vary between diferrent lots.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5-1.0 mg/mL
-
缓冲液
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
-
- EXOSC3 (Exosome Component 3 (EXOSC3))
-
别名
- EXOSC3
-
分子量
- 29.4 kDa
-
基因ID
- 51010
-
NCBI登录号
- NM_016042
-
HGNC
- 51010
-
途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
抗原
-
